SIB LLC’s Juno Therapeutics, Inc. JUNO Stock Holding History

SIB LLC’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-100,000	Closed	-$4.57M	–	26
2017 Q4	$4.57M	Hold	100,000	–	–	3.28%	12
2017 Q3	$4.49M	Hold	100,000	–	–	3.22%	12
2017 Q2	$2.99M	Hold	100,000	–	–	2.31%	14
2017 Q1	$2.22M	Hold	100,000	–	–	1.83%	18
2016 Q4	$1.89M	Hold	100,000	–	–	1.52%	18
2016 Q3	$3M	Buy	+100,000	New	+$3.11M	2.42%	16

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

SIB LLC's JUNO Position: Q1 2018 in Review

SIB LLC sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 100,000 shares — an estimated $4.57M sold.

SIB LLC first reported a position in JUNO in Q3 2016 and held it in 6 quarters. The position peaked at $4.57M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

SIB LLC reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
SIB LLC sold 100,000 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $4.57M.
SIB LLC first reported a position in Juno Therapeutics, Inc. in Q3 2016 and held it in 6 quarters.
SIB LLC's Juno Therapeutics, Inc. position peaked at $4.57M in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on SIB LLC's 13F filing for Q1 2018, filed 12 Apr 2018.